Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Gang Li, Ph.D.
Gang Li, Ph.D.


Professor, Department of Biostatistics
Director, UCLA Center for Excellence in Pancreatic Diseases, Biostatistics Subcore
Director, JCCC Biostatistics, Analytic Support and Evaluation (BASE) Shared Resource
Member, JCCC Cancer Molecular Imaging Program Area

Contact Information:

(310) 206-5865

Scientific Interest(s):

Dr. Gang Li's main research interest is the development of statistical methodology in survival analysis, longitudinal modeling, design and analysis of clinical trials, nonparametric/semiparametric inference, evaluation of medical diagnostic tests and medical imaging. Li collaborates extensively in cancer research including basic, translational and population research, as well as clinical trials for pancreatic cancer, prostate cancer, skin cancer and other cancers. Li is an Elected Fellow of the Institute of Mathematical Statistics, the American Statistical Association and the Royal Statistical Society and an Elected Member of the International Statistical Institute.

Selected Cancer-Related Publications:

King JC, Lu QY, Li G, Moro A, Takahashi H, Chen M, Go VL, Reber HA, Eibl G, Hines OJ. Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Biochim Biophys Acta. 2012 Feb;1823(2):593-604. Epub 2011 Dec 29

Reicher S, Boyar FZ, Albitar M, Sulcova V, Agersborg S, Nga V, Zhou Y, Li G, Venegas R, French SW, Chung DS, Stabile BE, Eysselein VE, Anguiano A. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses. Pancreas. 2011 Oct;40(7):1057-62.

Xie C, Kim HJ, Haw JG, Kalbasi A, Gardner BK, Li G, Rao J, Chia D, Liong M, Punzalan RR, Marks LS, Pantuck AJ, de la Taille A, Wang G, Mukouyama H, Zeng G. A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. J Transl Med. 2011 Apr 19;9:43.

Piche B, Khosravi S, Martinka M, Ho V, Li G. CDH22 expression is reduced in metastatic melanoma. Am J Cancer Res. 2011 Dec 10;1(2):233-239.

Woltering EA, Salvo VA, O'Dorisio TM, Lyons J, Li G, Zhou Y, Seward JR, Go VL, Vinik AI, Mamikunian P, Mamikunian G. Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients. Pancreas. 2008 Jul;37(1):94-100.